BVS
Price
$15.04
Change
+$0.80 (+5.62%)
Updated
Oct 22 closing price
Capitalization
1.03B
11 days until earnings call
Intraday BUY SELL Signals
ENOV
Price
$21.59
Change
+$0.78 (+3.75%)
Updated
Oct 22 closing price
Capitalization
1.25B
13 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BVS vs ENOV

BVS vs ENOV Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BVS vs. ENOV commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BVS is a StrongBuy and ENOV is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for BVS with price predictions
Oct 22, 2026

BVS in upward trend: 10-day moving average crossed above 50-day moving average on October 22, 2026

The 10-day moving average for BVS crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 87%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on BVS as a result. In 84 of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 86%.

The Moving Average Convergence Divergence (MACD) for BVS just turned positive on October 14, 2026. Looking at past instances where BVS's MACD turned positive, the stock continued to rise in 36 of 46 cases over the following month. The odds of a continued upward trend are 78%.

BVS moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +7.81% 3-day Advance, the price is estimated to grow further. Considering data from situations where BVS advanced for three days, in 221 of 277 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BVS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.

BVS broke above its upper Bollinger Band on October 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for BVS entered a downward trend on September 29, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 35 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. BVS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 79 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.500) is normal, around the industry mean (2.874). P/E Ratio (18.568) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (1.529) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (1.583) is also within normal values, averaging (40.124).

The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 96 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BVS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

A.I.Advisor
a Summary for ENOV with price predictions
Oct 22, 2026

ENOV's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for ENOV turned positive on September 23, 2026. Looking at past instances where ENOV's MACD turned positive, the stock continued to rise in 33 of 44 cases over the following month. The odds of a continued upward trend are 75%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 12, 2026. You may want to consider a long position or call options on ENOV as a result. In 44 of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 55%.

ENOV moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +4.35% 3-day Advance, the price is estimated to grow further. Considering data from situations where ENOV advanced for three days, in 156 of 254 cases, the price rose further within the following month. The odds of a continued upward trend are 61%.

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The 50-day moving average for ENOV moved below the 200-day moving average on September 25, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ENOV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.

ENOV broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ENOV entered a downward trend on October 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 18 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating steady price growth. ENOV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 78 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.843) is normal, around the industry mean (2.874). P/E Ratio (-1.119) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (3.441) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (0.466) is also within normal values, averaging (40.124).

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ENOV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

FUNDAMENTALS RATINGS
ENOV: Fundamental Ratings
ENOV
OUTLOOK RATING
1..100
27
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
18
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BVSENOV
RSI
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
62%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
80%
Momentum
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
55%
MACD
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
75%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
65%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
63%
Advances
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
61%
Declines
ODDS (%)
Bearish Trend 15 days ago
82%
Bearish Trend 15 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
66%
Aroon
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
69%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (BVS: $15.04 vs. ENOV: $21.59)
Brand notoriety: BVS and ENOV are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: BVS: 125% vs. ENOV: 81%
Market capitalization -- BVS: $1.03B vs. ENOV: $1.25B
BVS [@Medical/Nursing Services] is valued at $1.03B. ENOV’s [@Medical/Nursing Services] market capitalization is $1.25B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $177.38B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.7B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BVS’s FA Score shows that 0 FA rating(s) are green while ENOV’s FA Score has 1 green FA rating(s).

  • BVS’s FA Score: 0 green, 5 red.
  • ENOV’s FA Score: 1 green, 4 red.
According to our system of comparison, BVS is a better buy in the long-term than ENOV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BVS’s TA Score shows that 5 TA indicator(s) are bullish while ENOV’s TA Score has 4 bullish TA indicator(s).

  • BVS’s TA Score: 5 bullish, 5 bearish.
  • ENOV’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, BVS is a better buy in the short-term than ENOV.

Price Growth

BVS (@Medical/Nursing Services) experienced а +8.91% price change this week, while ENOV (@Medical/Nursing Services) price change was +11.58% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.50%. For the same industry, the average monthly price growth was -10.64%, and the average quarterly price growth was -10.25%.

Reported Earning Dates

BVS is expected to report earnings on Nov 03, 2026.

ENOV is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Medical/Nursing Services (-1.50% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
BVS
Daily Signal:
Gain/Loss:
ENOV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

BVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BVS has been loosely correlated with ENOV. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if BVS jumps, then ENOV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BVS
1D Price
Change %
BVS100%
+5.62%
ENOV - BVS
44%
Loosely correlated
+3.75%
CNMD - BVS
38%
Loosely correlated
+4.95%
OFIX - BVS
38%
Loosely correlated
+2.57%
KIDS - BVS
38%
Loosely correlated
+3.65%
TCMD - BVS
37%
Loosely correlated
+1.12%
More

ENOV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENOV has been loosely correlated with FELE. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ENOV jumps, then FELE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENOV
1D Price
Change %
ENOV100%
+3.75%
FELE - ENOV
56%
Loosely correlated
-2.01%
DOV - ENOV
55%
Loosely correlated
-2.18%
PH - ENOV
53%
Loosely correlated
-6.78%
ITT - ENOV
52%
Loosely correlated
-6.03%
KMT - ENOV
51%
Loosely correlated
-4.89%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WTW332.1814.56
+4.58%
Willis Towers Watson Public Limited
ARDX3.200.07
+2.24%
Ardelyx
KSCP0.52-0.01
-1.65%
Knightscope Inc
AIR96.67-2.97
-2.98%
AAR Corp
VLN1.47-0.14
-8.70%
Valens Semiconductor Ltd